These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22127852)

  • 21. Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.
    Santos JI; Teixeira AL; Dias F; Maurício J; Lobo F; Morais A; Medeiros R
    Tumour Biol; 2014 Jul; 35(7):7105-13. PubMed ID: 24760272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
    Majid S; Dar AA; Saini S; Arora S; Shahryari V; Zaman MS; Chang I; Yamamura S; Tanaka Y; Deng G; Dahiya R
    Cancer Res; 2012 Dec; 72(24):6435-46. PubMed ID: 23074286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
    Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
    J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
    Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
    Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
    Hörnberg E; Ylitalo EB; Crnalic S; Antti H; Stattin P; Widmark A; Bergh A; Wikström P
    PLoS One; 2011 Apr; 6(4):e19059. PubMed ID: 21552559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.
    Zhu J; Wang S; Zhang W; Qiu J; Shan Y; Yang D; Shen B
    Oncotarget; 2015 Dec; 6(41):43819-30. PubMed ID: 26540468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts.
    Locke JA; Nelson CC; Adomat HH; Hendy SC; Gleave ME; Guns ES
    J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):126-36. PubMed ID: 19442514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
    Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
    Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
    Grossi I; Arici B; Portolani N; De Petro G; Salvi A
    Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts.
    Yang Z; Xiao Z; Guo H; Fang X; Liang J; Zhu J; Yang J; Li H; Pan R; Yuan S; Dong W; Zheng XL; Wu S; Shan Z
    J Cell Mol Med; 2019 May; 23(5):3246-3256. PubMed ID: 30729664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
    Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
    Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer.
    He HC; Zhu JG; Chen XB; Chen SM; Han ZD; Dai QS; Ling XH; Fu X; Lin ZY; Deng YH; Qin GQ; Cai C; Chen JH; Zhong WD
    FEBS Lett; 2012 Jul; 586(16):2451-8. PubMed ID: 22710126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.